Amyloid and tau PET enable in vivo visualization of the underlying pathophysiologic culprits of AD, namely senile plaques and neurofibrillary tangles, but their clinical use may be affected by its availability, cost and consideration of ionizing radiation exposure. The gene discussed is MAPT; the disease is Alzheimer disease.